Literature DB >> 24651058

Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

Osman Sonmez1, Furkan U Ertem2, Mehmet Akif Vatankulu1, Ercan Erdogan1, Abdurrahman Tasal1, Sıtkı Kucukbuzcu1, Omer Goktekin1.   

Abstract

BACKGROUND: Structural remodeling is associated with the fibroinflammatory process in the atrial extracellular matrix. In the present study we aimed to investigate whether serum levels of new circulating remodeling markers differ in patients with atrial fibrillation (AF) compared to patients with sinus rhythm.
MATERIAL AND METHODS: The study population included 52 patients diagnosed with non-valvular AF and 33 age-matched patients with sinus rhythm. Serum levels of Galectin-3, matrix metalloproteinase-9 (MMP-9), lipocalin-2 (Lcn2/NGAL), N-terminal propeptide of type III procollagen (PIIINP), Hs-Crp, and neutrophil-to-lymphocyte ratio (NLR) were measured. The left atrial volume (LAV) was calculated by echocardiographic method and LAV index was calculated.
RESULTS: Galectin-3, MMP-9, and PIIINP levels were significantly higher in AF patients except NGAL levels (1166 pg/ml (1126-1204) and 1204 pg/ml (1166-1362) p=0.001, 104 (81-179) pg/ml and 404 (162-564) pg/ml p<0.0001, and 1101 (500-1960) pg/ml and 6710 (2370-9950) pg/ml p<0.0001, respectively). The NLR and Hs-CRP levels were also higher in AF (2.1 ± 1.0 and 2.7 ± 1.1 p=0.02 and 4.2 ± 1.9 mg/L and 6.0 ± 4.7 mg/L p=0.04, respectively). In correlation analyses, NLR showed a strongly significant correlation with LAVi, but Hs-CRP did not (p=0.007 r=0.247, Pearson test and p=0.808 r=0.025, Pearson test, respectively). Moreover, Galectin-3, MMP-9, and PIIINP had a strong positive correlation with LAVi (p=0.021 r=640, Spearman test and p=0.004 r=0.319 Pearson test, and p=0.004 r=0.325 Pearson test, respectively).
CONCLUSIONS: Novel fibrosis and inflammation markers in AF are correlated with atrial remodeling. Several unexplained mechanisms of atrial remodeling remain, but the present study has taken the first step in elucidating the mechanisms involving fibrosis and inflammation markers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24651058      PMCID: PMC3965288          DOI: 10.12659/MSM.890635

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  40 in total

1.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Authors:  A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 3.  Galectin-3: a novel blood test for the evaluation and management of patients with heart failure.

Authors:  Peter A McCullough; Ariyo Olobatoke; Thomas E Vanhecke
Journal:  Rev Cardiovasc Med       Date:  2011       Impact factor: 2.930

4.  Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension.

Authors:  Hiroyuki Sasamura; Yudai Kitamura; Mari Nakamura; Munekazu Ryuzaki; Takao Saruta
Journal:  Clin Exp Hypertens       Date:  2006-07       Impact factor: 1.749

Review 5.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

6.  Can neutrophil/lymphocyte ratio predict recurrence of non-valvular atrial fibrillation after cardioversion?

Authors:  Alpay Arıbaş; Hakan Akıllı; Enes Elvin Gül; Mehmet Kayrak; Kenan Demir; Cetin Duman; Hajrudin Alibasiç; Mehmet Yazıcı; Kurtuluş Ozdemir; Hasan Gök
Journal:  Anadolu Kardiyol Derg       Date:  2012-12-07

7.  Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.

Authors:  Giuseppe Licata; Antonino Tuttolomondo; Domenico Di Raimondo; Salvatore Corrao; Riccardo Di Sciacca; Antonio Pinto
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

8.  Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease.

Authors:  K M Choi; J S Lee; E J Kim; S H Baik; H S Seo; D S Choi; D J Oh; C G Park
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

Review 9.  A proposal for new clinical concepts in the management of atrial fibrillation.

Authors:  A John Camm; Sana M Al-Khatib; Hugh Calkins; Jonathan L Halperin; Paulus Kirchhof; Gregory Y H Lip; Stanley Nattel; Jeremy Ruskin; Amitava Banerjee; Dan Blendea; Eduard Guasch; Matthew Needleman; Irina Savelieva; Juan Viles-Gonzalez; Eric S Williams
Journal:  Am Heart J       Date:  2012-08-03       Impact factor: 4.749

10.  Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.

Authors:  Andreas S Kalogeropoulos; Sotirios Tsiodras; Angelos G Rigopoulos; Eleftherios A Sakadakis; Andreas Triantafyllis; Dimitrios Th Kremastinos; Ioannis Rizos
Journal:  BMC Cardiovasc Disord       Date:  2011-12-28       Impact factor: 2.298

View more
  20 in total

1.  Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Authors:  A Mantovani; R Rigolon; A Civettini; B Bolzan; G Morani; S Bonapace; C Dugo; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

Review 2.  Role of inflammation in atrial fibrillation pathophysiology and management.

Authors:  Masahide Harada; David R Van Wagoner; Stanley Nattel
Journal:  Circ J       Date:  2015-02-16       Impact factor: 2.993

3.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

Review 4.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

5.  Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Oluwaseun E Fashanu; Faye L Norby; David Aguilar; Christie M Ballantyne; Ron C Hoogeveen; Lin Y Chen; Elsayed Z Soliman; Alvaro Alonso; Aaron R Folsom
Journal:  Am Heart J       Date:  2017-07-08       Impact factor: 4.749

6.  Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation.

Authors:  Yao-Dong Li; Yi-Fan Hong; Yu Zhang; Xian-Hui Zhou; Yu-Tong Ji; Hong-Liang Li; Guo-Jun Hu; Jin-Xin Li; Lin Sun; Jiang-Hua Zhang; Qiang Xin; Yueerguli Yusufuaji; Jian Xiong; Bao-Peng Tang
Journal:  Med Sci Monit       Date:  2014-11-14

7.  The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.

Authors:  Gang Wu; Shun Wang; Mian Cheng; Bin Peng; Jingjun Liang; He Huang; Xuejun Jiang; Lizhi Zhang; Bo Yang; Yongmei Cha; Hong Jiang; Congxin Huang
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

Review 8.  Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke.

Authors:  István Szegedi; László Szapáry; Péter Csécsei; Zoltán Csanádi; László Csiba
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

Review 9.  Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.

Authors:  Alexander Weymann; Sadeq Ali-Hasan-Al-Saegh; Anton Sabashnikov; Aron-Frederik Popov; Seyed Jalil Mirhosseini; Tong Liu; Mohammadreza Lotfaliani; Michel Pompeu Barros de Oliveira Sá; William L L Baker; Senol Yavuz; Mohamed Zeriouh; Jae-Sik Jang; Hamidreza Dehghan; Lei Meng; Luca Testa; Fabrizio D'Ascenzo; Umberto Benedetto; Gary Tse; Luis Nombela-Franco; Pascal M Dohmen; Abhishek J Deshmukh; Cecilia Linde; Giuseppe Biondi-Zoccai; Gregg W Stone; Hugh Calkins; Integrated Meta-Analysis Of Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-05-12

Review 10.  Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.

Authors:  Alexander Weymann; Sadeq Ali-Hasan-Al-Saegh; Anton Sabashnikov; Aron-Frederik Popov; Seyed Jalil Mirhosseini; Luis Nombela-Franco; Luca Testa; Mohammadreza Lotfaliani; Mohamed Zeriouh; Tong Liu; Hamidreza Dehghan; Senol Yavuz; Michel Pompeu Barros de Oliveira Sá; William L Baker; Jae-Sik Jang; Mengqi Gong; Umberto Benedetto; Pascal M Dohmen; Fabrizio D'Ascenzo; Abhishek J Deshmukh; Giuseppe Biondi-Zoccai; Hugh Calkins; Gregg W Stone; Integrated Meta-Analysis Of Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.